aid: celaidtherapeutics

name: Celaidtherapeutics

image: https://celaidtx.com/wp/wp-content/themes/celaid/img/ogp_en.jpg

description: 'Celaidtherapeutics is a Japan‑based biotechnology company developing cell therapy products using cord‑blood‑derived hematopoietic stem cells. The firm aims to provide alternative treatments to bone‑marrow transplantation, focusing on leukemia, other blood cancers, and genetic disorders. It operates from Tokyo and collaborates with academic institutions and pharmaceutical partners.'

url: https://raw.githubusercontent.com/api-evangelist/celaidtherapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Cell Therapy
- Hematopoietic Stem Cells
- Regenerative Medicine
- Drug Discovery
- Blood Cancer
- Genetic Disorders

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/celaidtherapeutics-hosts.yml
- type: DomainSecurity
  url: security/celaidtherapeutics-domain-security.yml
- type: Website
  url: https://celaidtx.com/en/

- type: About
  url: https://celaidtx.com/en/about/
- type: Documentation
  url: https://celaidtx.com/en/tech/technology/
- type: Contact
  url: https://celaidtx.com/en/contact/
- type: PrivacyPolicy
  url: https://celaidtx.com/en/privacy/

apis: []

x-coverage:
  state: unreadable
  reason: js-rendered-docs
  detail: "Documentation pages are HTML rendered by JavaScript with no machine‑readable OpenAPI or other contract discovered."
  evidence:
    - url: https://celaidtx.com/en/tech/technology/
      status: 200
  checked: '2026-10-07'
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local